Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Nanomaterials (Basel, Switzerland)|July 25, 2019
Lights Out! Nano-Scale Topography Imaging of Sample Surface in Opaque Liquid Environments with Coated Active Cantilever ProbesFangzhou Xia, Chen Yang, Yi Wang, et al.Onkologie|June 1, 2011
Efficacy of sunitinib re-exposure after failure of an mTOR inhibitor in patients with metastatic RCCViktor Grünwald, Steffen Weikert, Christoph Seidel, et al.Frontiers in Pediatrics|April 13, 2023
Living in a box: Understanding acoustic parameters in the NICU environmentChristoph Reuter, Lisa Bartha-Doering, Isabella Czedik-Eysenberg, et al.World Journal of Urology|August 2, 2022
Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?Hendrik Eggers, Christoph Schünemann, Viktor Grünwald, et al.Frontiers in Pediatrics|May 6, 2024
"Every breath you take": evaluating sound levels and acoustic characteristics of various neonatal respiratory support and ventilation modalitiesSophie Stummer, Christoph Reuter, Isabella Czedik-Eysenberg, et al.Frontiers in Pediatrics|June 29, 2026
What's that noise-tackling sound pollution in the NICU: a systematic reviewVito Giordano, Sophie Mandl, Lisa Bartha-Doering, et al.Oncology Letters|January 27, 2017
Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapyChristoph A von Klot, Markus A Kuczyk, Alena Boeker, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 2, 2021
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert PerspectivesFrederik A Verburg, Holger Amthauer, Ina Binse, et al.Nature Materials|July 1, 2026
Quantum tunnelling and leakage current across two-dimensional materialsYue Yuan, Francesco Maria Puglisi, Andrea Padovani, et al.Cancer|March 22, 2012
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 studySusan Urba, Carla M L van Herpen, Tarini Prasad Sahoo, et al.Pageof 4